Gift Opening
$200 Off MarketBeat All Access
Thanks for being one of our best subscribers! You are eligible for a limited-time discount.
  •  days
  •  Hours
  •  Minutes
  •  Seconds
Claim Your Discount
×
Free Trial
NYSEARCA:XBI

SPDR S&P Biotech ETF (XBI) Price, Holdings, & News

$99.19
-2.40 (-2.36%)
(As of 09/23/2024 ET)

About SPDR S&P Biotech ETF (NYSEARCA:XBI)

Key Stats

Today's Range
$99.07
$102.13
50-Day Range
$92.37
$102.43
52-Week Range
$63.80
$103.52
Volume
9.97 million shs
Average Volume
9.75 million shs
Market Capitalization
$7.56 billion
Assets Under Management
$7.60 billion
Dividend Yield
0.02%
Net Expense Ratio
0.35%
Aggregate Rating
Moderate Buy

ETF Overview

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index. SSgA Funds Management, Inc. is the Fund's investment advisor.

SPDR S&P Biotech ETF Expenses

TypeXBIHealth Care ETFsEquity ETFsNYSEARCA ETFsAll ETFs
Management Fee0.35%0.56%0.54%0.51%0.52%
Other Expenses0.00%0.33%0.49%0.58%0.54%
Total Expense0.35%0.71%0.70%0.73%0.71%
Fee Waiver0.00%-0.45%-0.52%-0.68%-0.58%
Net Expense0.35%0.61%0.61%0.58%0.59%

XBI ETF News Headlines

Digital interface with hologram of dna and hud with icons of lungs, pills, thermometer, syringe, emergency call, diagnostics, pie diagram. Concept of future technologies in health care. 3d rendering — Photo
Biotech Boom Ahead? Key Stocks and ETFs to Watch Now (XBI)
The Federal Reserve's recent 50bps rate cut could significantly boost biotech companies by lowering borrowing costs and improving access to capital.
SPDR S&P Biotech ETF (NYSEARCA:XBI) Sets New 1-Year High at $103.52
320 hedge funds just sold this stock
320 hedge funds just sold this stock A strange force has seized control of Wall Street. Hedge funds are already moving their money… and preparing for even stranger days ahead. Over 320 hedge funds have quietly sold THIS famous stock – to prepare for a dramatic market shift
See More Headlines

XBI ETF - Frequently Asked Questions

SPDR S&P Biotech ETF's stock was trading at $89.29 at the beginning of 2024. Since then, XBI stock has increased by 11.1% and is now trading at $99.19.
View the best growth stocks for 2024 here
.

Top institutional shareholders of SPDR S&P Biotech ETF include Healthcare of Ontario Pension Plan Trust Fund (4.06%), Avoro Capital Advisors LLC (3.98%), Logos Global Management LP and Logos Global Management LP.

Shares of XBI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Based on aggregate information from My MarketBeat watchlists, some other companies that SPDR S&P Biotech ETF investors own include Intel (INTC), NVIDIA (NVDA), Pfizer (PFE), Gilead Sciences (GILD), iShares Biotechnology ETF (IBB), Walt Disney (DIS) and Micron Technology (MU).

Fund Details

Issuer
SSgA
Fund Name
SPDR S&P Biotech ETF
Tax Classification
Regulated Investment Company
Current Symbol
NYSEARCA:XBI
Inception Date
1/31/2006
Fund Manager
Michael Feehily, Karl Schneider, Raymond Donofrio

Fund Focus

Asset Class
Equity
Benchmark
S&P Biotech Index
Category
Sector
Focus
Health Care
Development Level
Developed Markets
Region
North America
Number of Holdings
143

Fund Statistics

Assets Under Management
$7.60 billion
Average Daily Volume
$7.02 million
Discount/Premium
0.04%

Administrator, Advisor and Custodian

Administrator
SSgA Funds Management, Inc.
Advisor
SSgA Funds Management, Inc.
Custodian
State Street Bank and Trust Company
Distributor
State Street Global Advisors Funds Distributors, LLC
Transfer Agent
State Street Bank and Trust Company
Trustee
N/A
Lead Market Maker
Virtu Financial

Options

Optionable
Optionable
Options Volume
55,977
Put Options
21,569
Call Options
34,408
Short Interest
55,500,000 shs

Miscellaneous

Beta
1.11
Creation Unit
50,000
Creation Fee
$250.00

Top 10 XBI Holdings

XBI Sector Exposure

XBI Industry Exposure


This page (NYSEARCA:XBI) was last updated on 9/23/2024 by MarketBeat.com Staff
From Our Partners